Pelareorep Completed Phase 3 Trials for Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment

Indications	Status	Purpose	Phase
DBCOND0035874 (Squamous Cell Carcinoma of the Head and Neck (SCCHN))	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT01166542	Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers	Carboplatin (DB00958) Paclitaxel (DB01229) Pelareorep (DB17284)